An Essential Partnership: Patient Advocates and Cooperative Groups

Seminars in Oncology

Volumn 35, Issue 5, 2008, Pages 553-555

  Collyar, Deborah ^a  

^a CALGB Committee on Advocacy Research Communication Ethics and Disparaties

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RESEARCH; CANCER THERAPY; HEALTH CARE; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL PRACTICE; PATIENT ADVOCACY; PRIORITY JOURNAL;

CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT ADVOCACY;

EID: 53149101351     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.07.009     Document Type: Article

References (5)

1. Collyar D.E. How have patient advocates in the United States benefited cancer research?. Nature Rev Cancer 5 (2005) 73-78
2. Demmy T.L., Yasko J.M., Collyar D.E., Katz M.L., Krasnov C.L., and Borwhat M.J. Managing accrual in cooperative group clinical trials. J Clin Oncol. 22 (2004) 2997-3002
3. Collyar D. Connecting clinical trials to people. National Cancer Policy Forum (NCPF) Multi-site Clinical Trials and the National Cancer Institute Cooperative Group Program: A Workshop. July 1-2, 2008. Institute of Medicine. http://www.iom.edu/CMS/26765/52301/54763.aspx Accessed July 30, 2008
4. The International Myeloma Foundation says ECOG results could improve survival while reducing side effects for many patients. http://myeloma.org/main.jsp?type=article&id=2056 Accessed February 1, 2008
5. Michaels M., and Collyar D. Research advocacy in traditional research settings: questions of influence and legitimacy. In: Earp J.A., French E.A., and Glikey M.B. (Eds). Patient advocacy for health care quality (2007), Jones & Barlett, Sudbury, MA 445-478